A Study to Compare mRNA-1273 Versus BNT162b2 COVID-19 Vaccines Among Immunocompromised Adults

NCT05366322 · clinicaltrials.gov ↗
COMPLETED
Status
124879
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

ModernaTX, Inc.